FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2101039575> ?p ?o ?g. }

• W2101039575 endingPage "468" @default.
• W2101039575 startingPage "464" @default.
• W2101039575 abstract "No AccessJournal of UrologyClinical Urology: Original Article1 Aug 1996Detection of prostate specific antigen in pancreas and salivary glands: a potential impact on prostate cancer overestimation Abdel-Aziz A. Elgamal, Nadine L. Ectors, S. Sunardhi-Widyaputra, Hein P. Van Poppel, Boudewyn J. Van Damme, and Luc V. Baert Abdel-Aziz A. ElgamalAbdel-Aziz A. Elgamal More articles by this author , Nadine L. EctorsNadine L. Ectors More articles by this author , S. Sunardhi-WidyaputraS. Sunardhi-Widyaputra More articles by this author , Hein P. Van PoppelHein P. Van Poppel More articles by this author , Boudewyn J. Van DammeBoudewyn J. Van Damme More articles by this author , and Luc V. BaertLuc V. Baert More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(01)65883-XAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: We explored the immunohistochemical expression of prostate specific antigen (PSA) in pancreas and salivary glands. Materials and Methods: We investigated 62 specimens from male and female subjects, representing normal cases and several pathological conditions of pancreas and salivary glands. Two commercially available monoclonal antisera for PSA and 1 for prostatic acid phosphatase were used. Results: A consistently positive reaction for PSA and prostatic acid phosphatase, independent of patient sex, was noted in ductal cells of normal pancreas and normal salivary glands, as well as pleomorphic adenoma, adenocarcinoma and all oncocytic epithelial cells of Warthin's tumor. Reaction was absent in normal stromal and acinar cells, and squamous carcinoma. Conclusions: PSA is detectable in normal and cancer tissues far from the prostate. Therefore, we may not entirely rely on specificity of PSA alone to diagnose metastatic prostate cancer. References 1 : Demonstration of the prostatic origin of metastases: an immunohistochemical method for formalin-fixed embedded tissue. Cancer1978; 41: 1788. Google Scholar 2 : Prostatic origin of tumors. An immunohistochemical study. Amer. J. Clin. Path.1980; 73: 735. Google Scholar 3 : Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms. Cancer1981; 48: 1229. Google Scholar 4 : Prostate specific antigen: a marker for human prostate epithelial cells. J. Natl. Cancer Inst.1981; 66: 37. Google Scholar 5 : Improved immunohistochemical detection of prostatic acid phosphatase by a monoclonal antibody. Prostate1989; 15: 13. Google Scholar 6 : PSA and PAP as immunohistochemical markers in prostate cancer. Urol. Clin. N. Amer.1993; 20: 757. Google Scholar 7 : Prostate specific antigen: a critical assessment of the most useful marker for adenocarcinoma of the prostate. J. Urol.1991; 145: 907. Link, Google Scholar 8 : Prostate-specific antigen. Current role in diagnostic pathology of prostate cancer. Amer. J. Clin. Path.1994; 102: S31. Google Scholar 9 : Extraprostatic localization of prostatic acid phosphatase and prostate-specific antigen: distribution in cloacogenic glandular epithelium and sex-dependent expression in human anal gland. Hum. Path.1990; 21: 1108. Google Scholar 10 : Immunohistochemical localization of prostate-specific markers within the accessory male sex glands of Cowper, Littre and Morgagni. Urology1994; 44: 84. Google Scholar 11 : Immunoreactive prostatic specific antigen in male peri-urethral glands. J. Urol.1992; 147: 246. Abstract, Google Scholar 12 : An analysis of urinary prostate specific antigen before and after radical prostatectomy: evidence for secretion of prostate specific antigen by the periurethral glands. J. Urol.1993; 149: 783. Link, Google Scholar 13 : Urinary prostate specific antigen levels after radical prostatectomy. J. Urol.1994; 151: 82. Link, Google Scholar 14 : Exophytic papillary prostatic duct adenocarcinoma with endometrioid features, occurring in prostatic urethra after TURP. Urology1994; 43: 737. Google Scholar 15 : Prostate marker immunoreactivity in salivary gland neoplasms. A rare pitfall in immunohistochemistry. Amer. J. Surg. Path.1993; 17: 410. Google Scholar 16 : False-positive serum prostate-specific antigen values in a patient with non-Hodgkin lymphoma of the kidney. Urology1995; 45: 875. Google Scholar 17 : Postcoital detection of a male-specific semen protein. Application to the investigation of rape. New Engl. J. Med.1985; 312: 338. Google Scholar 18 : Prostate-specific antigen in urine and saliva. J. Urol.1993; 149: 302A. part 2, abstract 359. Google Scholar 19 : Classification of salivary gland neoplasms. In: Surgical Pathology of the Salivary Glands. Edited by . Philadelphia: W. B. Saunders Co.1991: 129. chapt. 8. Google Scholar 20 : Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Urology1995; 45: 729. Google Scholar 21 : Glandular kallikreins and prostate-specific antigen are expressed in the human endometrium. J. Clin. Endocr. Metab.1994; 78: 1536. Google Scholar 22 : Molecular characterization of prostate-specific antigen messenger RNA expressed in breast tumors. Cancer Res.1994; 54: 6344. Google Scholar 23 : Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen. J. Clin. Endocr. Metab.1993; 77: 229. Google Scholar 24 : Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J. Urol.1994; 151: 1283. Abstract, Google Scholar 25 : Early detection of residual prostate cancer after radical prostatectomy by an ultrasensitive assay for prostate specific antigen. J. Urol.1993; 149: 787. Link, Google Scholar 26 : Measurement of serum prostate specific antigen levels in women and in prostatectomized men with an ultrasensitive immunoassay technique. J. Urol.1995; 153: 1004. part 2. Link, Google Scholar 27 : Measurement of serum prostate specific antigen using IMx prostate specific antigen assay. J. Urol.1994; 151: 94. Link, Google Scholar 28 : Is prostate specific antigen of clinical importance in evaluating outcome after radical prostatectomy?. J. Urol.1993; 149: 516. Link, Google Scholar 29 : Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. Urol. Clin. N. Amer.1993; 20: 713. Google Scholar 30 : Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer. J. Urol.1992; 147: 942. part 2. Link, Google Scholar 31 : Editorial comment, J. Urol.1995; 154: 307. Google Scholar 32 : Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res.1994; 54: 6306. Google Scholar 33 : Identification of bone marrow micrometastases in patients with prostate cancer. Cancer1994; 74: 2533. Google Scholar 34 : Enhanced reverse transcriptase-polymerase chain reaction for prostate-specific antigen as an indicator of true pathologic stage in patients with prostate cancer. Cancer1995; 75: 1642. Google Scholar 35 : Prostate-specific antigen messenger RNA is expressed in non-prostate cells: implications for detection of micrometastases. Cancer Res.1995; 55: 2640. Google Scholar Department of Urology and Laboratory of Histochemistry and Cytochemistry, University Hospitals of KU Leuven, Leuven, Belgium.© 1996 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited byKoulikov D, Mohler M, Mehedint D, Attwood K, Wilding G and Mohler J (2018) Low Detectable Prostate Specific Antigen after Radical Prostatectomy—Treat or Watch?Journal of Urology, VOL. 192, NO. 5, (1390-1396), Online publication date: 1-Nov-2014.Zaviacic M and Ablin R (2018) RE: DETECTION OF PROSTATE SPECIFIC ANTIGEN IN PANCREAS AND SALIVARY GLANDSJournal of Urology, VOL. 160, NO. 4, (1441-1441), Online publication date: 1-Oct-1998. Volume 156Issue 2August 1996Page: 464-468 Advertisement Copyright & Permissions© 1996 by American Urological Association, Inc.MetricsAuthor Information Abdel-Aziz A. Elgamal More articles by this author Nadine L. Ectors More articles by this author S. Sunardhi-Widyaputra More articles by this author Hein P. Van Poppel More articles by this author Boudewyn J. Van Damme More articles by this author Luc V. Baert More articles by this author Expand All Advertisement PDF downloadLoading ..." @default.
• W2101039575 created "2016-06-24" @default.
• W2101039575 creator A5005699520 @default.
• W2101039575 creator A5007590098 @default.
• W2101039575 creator A5020783848 @default.
• W2101039575 creator A5049427382 @default.
• W2101039575 creator A5056226886 @default.
• W2101039575 creator A5066736633 @default.
• W2101039575 date "1996-08-01" @default.
• W2101039575 modified "2023-09-27" @default.
• W2101039575 title "Detection of prostate specific antigen in pancreas and salivary glands: a potential impact on prostate cancer overestimation" @default.
• W2101039575 cites W1527010159 @default.
• W2101039575 cites W1552193435 @default.
• W2101039575 cites W155375076 @default.
• W2101039575 cites W16556138 @default.
• W2101039575 cites W1901038908 @default.
• W2101039575 cites W1977749034 @default.
• W2101039575 cites W1980851683 @default.
• W2101039575 cites W1984566063 @default.
• W2101039575 cites W1992272100 @default.
• W2101039575 cites W1995565812 @default.
• W2101039575 cites W1996902585 @default.
• W2101039575 cites W1997501760 @default.
• W2101039575 cites W2008556945 @default.
• W2101039575 cites W2011820948 @default.
• W2101039575 cites W2013820259 @default.
• W2101039575 cites W2019609101 @default.
• W2101039575 cites W2022396538 @default.
• W2101039575 cites W2031660895 @default.
• W2101039575 cites W205537804 @default.
• W2101039575 cites W2055714694 @default.
• W2101039575 cites W2061734101 @default.
• W2101039575 cites W2063108219 @default.
• W2101039575 cites W2070492192 @default.
• W2101039575 cites W2076855482 @default.
• W2101039575 cites W2086092801 @default.
• W2101039575 cites W2089335503 @default.
• W2101039575 cites W2103117450 @default.
• W2101039575 cites W2105514165 @default.
• W2101039575 cites W2138542824 @default.
• W2101039575 cites W2168240583 @default.
• W2101039575 cites W2171181912 @default.
• W2101039575 cites W2235954515 @default.
• W2101039575 cites W2321867037 @default.
• W2101039575 cites W2333960687 @default.
• W2101039575 cites W2339258587 @default.
• W2101039575 cites W2396282348 @default.
• W2101039575 cites W2396518273 @default.
• W2101039575 cites W2398137194 @default.
• W2101039575 cites W2416860602 @default.
• W2101039575 cites W2417541366 @default.
• W2101039575 cites W2417728994 @default.
• W2101039575 cites W2422108216 @default.
• W2101039575 cites W27466347 @default.
• W2101039575 cites W327310168 @default.
• W2101039575 cites W351988627 @default.
• W2101039575 cites W36784297 @default.
• W2101039575 cites W62660674 @default.
• W2101039575 cites W64304463 @default.
• W2101039575 cites W2209826608 @default.
• W2101039575 doi "https://doi.org/10.1016/s0022-5347(01)65883-x" @default.
• W2101039575 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8683704" @default.
• W2101039575 hasPublicationYear "1996" @default.
• W2101039575 type Work @default.
• W2101039575 sameAs 2101039575 @default.
• W2101039575 citedByCount "47" @default.
• W2101039575 countsByYear W21010395752013 @default.
• W2101039575 countsByYear W21010395752014 @default.
• W2101039575 countsByYear W21010395752015 @default.
• W2101039575 countsByYear W21010395752016 @default.
• W2101039575 countsByYear W21010395752017 @default.
• W2101039575 countsByYear W21010395752018 @default.
• W2101039575 countsByYear W21010395752019 @default.
• W2101039575 countsByYear W21010395752023 @default.
• W2101039575 crossrefType "journal-article" @default.
• W2101039575 hasAuthorship W2101039575A5005699520 @default.
• W2101039575 hasAuthorship W2101039575A5007590098 @default.
• W2101039575 hasAuthorship W2101039575A5020783848 @default.
• W2101039575 hasAuthorship W2101039575A5049427382 @default.
• W2101039575 hasAuthorship W2101039575A5056226886 @default.
• W2101039575 hasAuthorship W2101039575A5066736633 @default.
• W2101039575 hasConcept C121608353 @default.
• W2101039575 hasConcept C126322002 @default.
• W2101039575 hasConcept C126894567 @default.
• W2101039575 hasConcept C142724271 @default.
• W2101039575 hasConcept C143998085 @default.
• W2101039575 hasConcept C147483822 @default.
• W2101039575 hasConcept C203014093 @default.
• W2101039575 hasConcept C2776235491 @default.
• W2101039575 hasConcept C2778764654 @default.
• W2101039575 hasConcept C2780192828 @default.
• W2101039575 hasConcept C2781406297 @default.
• W2101039575 hasConcept C71924100 @default.
• W2101039575 hasConcept C87874733 @default.
• W2101039575 hasConceptScore W2101039575C121608353 @default.
• W2101039575 hasConceptScore W2101039575C126322002 @default.
• W2101039575 hasConceptScore W2101039575C126894567 @default.
• W2101039575 hasConceptScore W2101039575C142724271 @default.

• next